2024-03-29T00:29:57Z
http://revistes.ub.edu/index.php/index/oai
oai:revistes.ub.edu:article/15153
2022-01-20T12:08:44Z
JESB:NR
driver
v2
http://revistes.ub.edu/index.php/JESB/article/view/j020
2022-01-20T12:08:44Z
U
Vol. 1 No 2 (2016): Special Issue International Business in Southern Europe in a Long-Term Perspective; 276-302
Historical Drawbacks of Limited Liability
Boyle, Denis; Universitat de Barcelona
2016-07-18
url:http://revistes.ub.edu/index.php/JESB/article/view/j020
JEL Classification
A13 Relation of Economics to Social Values
G32 - Financing Policy
Capital and Ownership Structure
M14 – Corporate Culture
Social Responsibility
Array
Limited liability is a human invention which has facilitated enormous economic growth around the world, particularly since the time of its general application in advanced countries during the nineteenth century. The individual legal identity of companies, coupled with the limited liability of their owners, has provided protection for investors from the risks associated with their investments. It has thus contributed to increase the sources of capital available to finance projects which might otherwise have been considered unviable. However, the legal protection offered to investors has negative consequences for other participants in economies. Speculation in stock markets often damages society. It is very important to study the drawbacks of limited liability and to suggest modifications to achieve a more stable, less volatile, economic growth in the world. Although this article goes to some lengths to recognise the work of authors who emphasise the positive historical economic contribution of limited lability, its main objective is to provoke a reflection around texts which point out the drawbacks and propose solutions.
oai:revistes.ub.edu:article/16233
2022-01-20T12:08:44Z
JESB:NR
driver
v2
http://revistes.ub.edu/index.php/JESB/article/view/j019
2022-01-20T12:08:44Z
U
Vol. 1 No 2 (2016): Special Issue International Business in Southern Europe in a Long-Term Perspective; 266-275
Laboratorios Andrómaco: Origins of the First Subsidiary of a Spanish Pharmaceutical Multinational in the United States (1928–1946)
Fernández Pérez, Paloma; Universitat de Barcelona (UB)
2016-07-18
url:http://revistes.ub.edu/index.php/JESB/article/view/j019
A
C
D
H
T
Z
Array
Laboratorios Andrómaco was a Spanish pharmaceutical company that opened a commercial subsidiary in the United States in the early months of 1929. It was located right in the heart of Manhattan, at 11 West 47th Street, in front of the New York Public Library. Despite the Wall Street crash, it remained open until 1946. The owner was the pharmacist-entrepreneur Fernando Rubió Tudurí (1900–1994). It was the first foreign direct investment made by a Spanish pharmaceutical multinational in the United States, using a maquila-style operation to export Spanish products made in the USA to Central American markets. Nothing has been published about this until now. Only interviews with Enrique and Mercè Rubió Boada (son and daughter of Fernando Rubió), digitalized sources from the company held by the Fundació Rubió Tudurí in Mahón, Minorca, and hard-to-access secondary sources have made the recovery of this history possible. The company closed its doors in the US and expanded in South American markets after World War II, but the short history of their investment in the United States reveals the potential and international capabilities of Spanish pharmaceutical companies before the Spanish Civil War. Moreover, it reveals how the Spanish Civil War was a disaster for millions of people but in some special cases it became an opportunity for companies in the science industries. Few pharmaceutical firms like Andrómaco, with entrepreneurs, resources, and a long-term vision, took the decision to invest in the most profitable (though also the most difficult) market for pharmaceutical products in the world: the United States. Andrómaco was created in Barcelona in 1923 by two scientist-entrepreneurs (Raul Roviralta and Fernando Rubió Tudurí). A nutritional product called Glefina (made with Norwegian cod oil from Ålesund and sugar) brought the small firm considerable success in sales in Spain in the mid-1920s. Making use of impressive networks (with the Spanish royal family, Catalan political elites, and the medical and pharmaceutical profession in Spain and Germany) and innovative commercial approaches (sending free samples to selected clients like King Alfonso XIII’s family circle and Dr Gregorio Marañón) were key business strategies during those years. The commercial subsidiary had two employees that coordinated the outsourcing of the production to local US producers, with exports of their US-made Andrómaco products going to Central American clients. Those clients loved buying a US-made product designed and sold by a Spanish pharmacist living in Long Island, with an office in Manhattan, who frequently travelled from the US to Latin America in the tough years of the Depression
oai:revistes.ub.edu:article/28665
2022-01-20T12:12:53Z
JESB:NR
driver
v2
http://revistes.ub.edu/index.php/JESB/article/view/j065
2022-01-20T12:12:53Z
U
Vol. 4 No 2 (2019): Special Issue: Presence of Chinese Businesses in the World; 204-209
Chinese companies in the world
Nueno, Pedro; IESE
2019-07-12
url:http://revistes.ub.edu/index.php/JESB/article/view/j065
Array
Over the next few years, we are going to see a major global expansion of Chinese companies in all sectors and in all countries. Obviously, this is an opportunity for companies whose future is not so clear-cut, be it because of their size, their technological weaknesses or their owners’ failing business interests (for reasons of age, family matters, diversification, etc.). However, it should be an opportunity for Chinese companies to expand their operations in Europe or in America. In many cases, such acquisitions (some of which have already been completed) will protect jobs and create many more. We should see the internationalization of Chinese companies as a great opportunity, and we should prepare ourselves for it and make sure we have the right strategies in place be it as partners, allies, suppliers or customers.
oai:revistes.ub.edu:article/30146
2022-01-20T12:02:08Z
JESB:NR
driver
v2
http://revistes.ub.edu/index.php/JESB/article/view/j074
2022-01-20T12:02:08Z
U
Vol. 5 No 1 (2020): Special Issue: Entrepreneurial and Innovation Ecosystems; 265-283
Culture and university entrepreneurship
Corona Treviño, Leonel; Facultad de Economía Universidad Nacional Autónoma de México
2020-01-30
url:http://revistes.ub.edu/index.php/JESB/article/view/j074
Array
Latin American universities typically fulfil the functions of teaching, research and the dissemination of culture. To become entrepreneurial universities, they incorporate knowledge transfer or, more generally, the commercialization of academic research and involvement in socio-economic development. However, proposals have been made to treat culture as a horizontal activity that also encompasses the creation of university cultural enterprises. To achieve this requires the crossing of the Arts and Sciences and the promotion of the resulting knowledge transfer. Here, an exploratory study of 16 cultural firms in Mexico allows us to identify strategies aimed at enhancing the entrepreneurial potential of the universities’ cultural activities in the country.
oai:revistes.ub.edu:article/36443
2022-07-01T10:50:49Z
JESB:NR
driver
v2
http://revistes.ub.edu/index.php/JESB/article/view/36443
2022-07-01T10:50:49Z
U
Vol. 7 No 2 (2022); 298-320
L'exploració i les pràctiques de TusPark en la promoció de la incubació empresarial i el desenvolupament industrial
Zhang, Tony; Tus-Holdings Co., Ltd.
Gao, Jian; Tsinghua University
2022-07-01
url:http://revistes.ub.edu/index.php/JESB/article/view/36443
Com a nova plataforma per a la innovació, els parcs científics universitaris nacionals de la Xina reuneixen una gran quantitat de recursos per a la innovació. No només són portadors de nous coneixements, tecnologies i sistemes, sinó també els de noves cultures. Com a un dels primers parcs científics universitaris nacionals de la Xina, TusPark, que compta amb el suport de la Universitat de Tsinghua amb la participació activa de diverses institucions empresarials, d'R+D i financeres, ha desenvolupat bàsicament una xarxa ecològica per a la innovació que es distribueix per tot el país. S'ha convertit en una plataforma important per a una major transformació dels assoliments científics i tecnològics de les universitats, així com per promoure el desenvolupament d'indústries emergents estratègiques. Centrat en les funcions i els papers de TusPark en l'avanç de la incubació d'empreses i el desenvolupament industrial, aquest article realitza una anàlisi en profunditat del camí de desenvolupament de TusPark, amb investigacions basades en entrevistes realitzades amb persones implicades en la construcció i les operacions de TusPark, així com en la revisió de la història del desenvolupament i models de parcs científics universitaris globals amb perspectives internacionals i extreure el camí i el model de desenvolupament únics de TusPark. L'objectiu d'aquest article és analitzar com TusPark, com a parc científic de la millor universitat de la Xina, va obrir un camí per a la incubació d'empreses i el desenvolupament industrial. El document presenta alguns casos típics i explica els principals models de TusPark per a la incubació d'empreses i el cultiu de la indústria. També analitza els principals factors de l'èxit de TusPark i explora els seus enfocaments per fomentar el desenvolupament futur en noves circumstàncies nacionals i internacionals.